140 related articles for article (PubMed ID: 32028479)
1. Squamous Cell Carcinoma of the Hand: A Retrospective Study in Immunosuppressed and Immunocompetent Individuals.
Mull JL; Phelan PS; Mull AB; Russell AJ; Hurst EA; Council ML
Dermatol Surg; 2020 Aug; 46(8):1014-1020. PubMed ID: 32028479
[TBL] [Abstract][Full Text] [Related]
2. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma.
Pugliano-Mauro M; Goldman G
Dermatol Surg; 2010 Oct; 36(10):1544-53. PubMed ID: 21053415
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
4. Histologic Status of Squamous Cell Carcinoma In Situ After Diagnostic Biopsy in Immunocompetent and Immunosuppressed Patients.
Moioli EK; Hsieh C; Tisch A; Bolotin D
Dermatol Surg; 2018 Mar; 44(3):341-349. PubMed ID: 29053535
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
6. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with large cutaneous squamous cell carcinomas.
Renzi C; Mastroeni S; Passarelli F; Mannooranparampil TJ; Caggiati A; Potenza C; Pasquini P
J Am Acad Dermatol; 2010 Sep; 63(3):404-11. PubMed ID: 20598396
[TBL] [Abstract][Full Text] [Related]
9. Multiple Cutaneous Squamous Cell Carcinoma in Immunosuppressed vs Immunocompetent Patients.
Gonzalez JL; Reddy ND; Cunningham K; Silverman R; Madan E; Nguyen BM
JAMA Dermatol; 2019 May; 155(5):625-627. PubMed ID: 30865240
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrent and metastatic cutaneous squamous cell carcinoma in immunocompromised patients.
Dong J; Lee T; Desman GT; Ratner D
J Am Acad Dermatol; 2020 Nov; 83(5):1473-1475. PubMed ID: 32199888
[No Abstract] [Full Text] [Related]
11. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
13. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
Varki V; Ioffe OB; Bentzen SM; Heath J; Cellini A; Feliciano J; Zandberg DP
Cancer Immunol Immunother; 2018 May; 67(5):805-814. PubMed ID: 29484464
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases.
Alam M; Caldwell JB; Eliezri YD
J Am Acad Dermatol; 2003 Mar; 48(3):385-93. PubMed ID: 12637918
[TBL] [Abstract][Full Text] [Related]
15. Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients.
Genders RE; Osinga JAJ; Tromp EE; O'Rourke P; Bouwes Bavinck JN; Plasmeijer EI
Acta Derm Venereol; 2018 Jun; 98(6):551-555. PubMed ID: 29405246
[TBL] [Abstract][Full Text] [Related]
16. A 5-year follow-up study of 633 cutaneous SCC excisions: Rates of local recurrence and lymph node metastasis.
Khan K; Mykula R; Kerstein R; Rabey N; Bragg T; Crick A; Heppell S; Budny P; Potter M
J Plast Reconstr Aesthet Surg; 2018 Aug; 71(8):1153-1158. PubMed ID: 29803777
[TBL] [Abstract][Full Text] [Related]
17. Metastases from squamous cell carcinoma of the skin in southern Australia.
Czarnecki D; Staples M; Mar A; Giles G; Meehan C
Dermatology; 1994; 189(1):52-4. PubMed ID: 8003787
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Differentiation Grade of Cutaneous Squamous Cell Carcinoma on Excision Margins, Local Recurrence, Metastasis, and Patient Survival: A Retrospective Follow-Up Study.
Brinkman JN; Hajder E; van der Holt B; Den Bakker MA; Hovius SE; Mureau MA
Ann Plast Surg; 2015 Sep; 75(3):323-6. PubMed ID: 24401812
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the hand: a 20-year review.
Askari M; Kakar S; Moran SL
J Hand Surg Am; 2013 Nov; 38(11):2124-33. PubMed ID: 24054071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
